CCL11 has been shown to induce degranulation and EDN release from human eosinophils and contribute to cytolysis of eosinophils in mice which could potentially explain the counterintuitive finding of eosinopenia and elevated secondary granules in COVID-19 patients (59–61). The gene discussed is CCL11; the disease is COVID-19.